Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05468697 |
| Title | A Study of Belzutifan (MK-6482) in Combination With Palbociclib Versus Belzutifan Monotherapy in Participants With Advanced Renal Cell Carcinoma (MK-6482-024) |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Merck Sharp & Dohme LLC |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Georgetown University Medical Center ( Site 1002) | RECRUITING | Washington | District of Columbia | 20007 | United States | Details |
| Beth Israel Deaconess Medical Center-Cancer Clinical Trials Office ( Site 1001) | RECRUITING | Boston | Massachusetts | 02215 | United States | Details |
| Huntsman Cancer Institute-HCI Clinical Trials Office ( Site 1004) | RECRUITING | Salt Lake City | Utah | 84112 | United States | Details |
| Macquarie University-MQ Health Clinical Trials Unit ( Site 2001) | RECRUITING | Macquarie University | New South Wales | 2109 | Australia | Details |
| Rambam Health Care Campus-Oncology ( Site 3000) | RECRUITING | Haifa | 3109601 | Israel | Details |